How to buy Quest Diagnostics Incorporated (DGX) shares in Australia
Learn how to easily invest in Quest Diagnostics Incorporated shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Quest Diagnostics Incorporated (DGX) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$134.23 after a previous close of US$133.87. During the day the price has varied from a low of USD133.71 to a high of USD135.15. The latest price was USD135.04 (25 minute delay). Quest Diagnostics Incorporated is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Quest Diagnostics Incorporated
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Quest Diagnostics Incorporated. Find the share by name or ticker symbol: DGX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Quest Diagnostics Incorporated reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$133.87, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Quest Diagnostics Incorporated, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Quest Diagnostics Incorporated. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Quest Diagnostics Incorporated key stats
- Compare share trading platforms
- Is Quest Diagnostics Incorporated stock a buy or sell?
- Quest Diagnostics Incorporated performance over time
- Is Quest Diagnostics Incorporated suitable for ethical investing?
- Are Quest Diagnostics Incorporated shares over-valued?
- Quest Diagnostics Incorporated's financials
- How volatile are Quest Diagnostics Incorporated shares?
- Does Quest Diagnostics Incorporated pay a dividend?
- Have Quest Diagnostics Incorporated shares ever split?
- Other common questions
Quest Diagnostics Incorporated stock price (NYSE:DGX)Use our graph to track the performance of DGX stocks over time.
Quest Diagnostics Incorporated shares at a glance
|52-week range||US$111.8094 - US$174.16|
|50-day moving average||US$156.6408|
|200-day moving average||US$143.8363|
|Dividend yield||US$2.42 (1.74%)|
|Earnings per share (TTM)||US$16.633|
Where to buy Quest Diagnostics Incorporated stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Quest Diagnostics Incorporated stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Quest Diagnostics Incorporated price performance over time
|1 week (2022-01-13)||-6.88%|
|1 month (2021-12-23)||-19.16%|
|3 months (2021-10-22)||-7.82%|
|6 months (2021-07-23)||-3.15%|
|1 year (2021-01-22)||8.50%|
|2 years (2020-01-23)||25.05%|
|3 years (2019-01-23)||56.46%|
|5 years (2017-01-23)||48.28%|
Stocks similar to Quest Diagnostics Incorporated
Is Quest Diagnostics Incorporated under- or over-valued?
Valuing Quest Diagnostics Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quest Diagnostics Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Quest Diagnostics Incorporated's P/E ratio
Quest Diagnostics Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Quest Diagnostics Incorporated shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Quest Diagnostics Incorporated's PEG ratio
Quest Diagnostics Incorporated's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 40.1904. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quest Diagnostics Incorporated's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Quest Diagnostics Incorporated's EBITDA
Quest Diagnostics Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.1 billion (£2.3 billion).
The EBITDA is a measure of a Quest Diagnostics Incorporated's overall financial performance and is widely used to measure a its profitability.
Quest Diagnostics Incorporated financials
|Revenue TTM||US$11 billion|
|Operating margin TTM||24.75%|
|Gross profit TTM||US$3.7 billion|
|Return on assets TTM||12.33%|
|Return on equity TTM||34.92%|
|Market capitalisation||US$17.5 billion|
TTM: trailing 12 months
Quest Diagnostics Incorporated's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Quest Diagnostics Incorporated.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Quest Diagnostics Incorporated's total ESG risk score
Total ESG risk: 18.33
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Quest Diagnostics Incorporated's overall score of 18.33 (as at 12/31/2018) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Quest Diagnostics Incorporated is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Quest Diagnostics Incorporated's environmental score
Environmental score: 0.86/100
Quest Diagnostics Incorporated's environmental score of 0.86 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Quest Diagnostics Incorporated's social score
Social score: 10.42/100
Quest Diagnostics Incorporated's social score of 10.42 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Quest Diagnostics Incorporated's governance score
Governance score: 5.77/100
Quest Diagnostics Incorporated's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Quest Diagnostics Incorporated is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Quest Diagnostics Incorporated's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Quest Diagnostics Incorporated scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Quest Diagnostics Incorporated hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||18.33|
|Total ESG percentile||16.26|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||3|
Quest Diagnostics Incorporated share dividends
Dividend payout ratio: 16.12% of net profits
Recently Quest Diagnostics Incorporated has paid out, on average, around 16.12% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.74% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quest Diagnostics Incorporated shareholders could enjoy a 1.74% return on their shares, in the form of dividend payments. In Quest Diagnostics Incorporated's case, that would currently equate to about $2.42 per share.
While Quest Diagnostics Incorporated's payout ratio might seem low, this can signify that Quest Diagnostics Incorporated is investing more in its future growth.
Quest Diagnostics Incorporated's most recent dividend payout was on 1 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 17 January 2022 (the "ex-dividend date").
Have Quest Diagnostics Incorporated's shares ever split?
Quest Diagnostics Incorporated's shares were split on a 2:1 basis on 20 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Quest Diagnostics Incorporated shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Quest Diagnostics Incorporated shares which in turn could have impacted Quest Diagnostics Incorporated's share price.
Quest Diagnostics Incorporated share price volatility
Over the last 12 months, Quest Diagnostics Incorporated's shares have ranged in value from as little as US$111.8094 up to US$174.16. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quest Diagnostics Incorporated's is 1.0218. This would suggest that Quest Diagnostics Incorporated's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Quest Diagnostics Incorporated overview
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated in the news
Down 17.9% in 4 Weeks, Here's Why Quest Diagnostics (DGX) Looks Ripe for a Turnaround
Will Quest Diagnostics Stock Rebound After A Large 19% Fall In A Month?
Bridge to Health Connects New Mexico Residents to Local Resources to Help Families Live Healthier Lives
Frequently asked questions
More guides on Finder
Top 10 TV shows in Australia this week and where to watch them
A fun superhero series, an epic sci-fi and a dark teen drama are among our top picks this week.
N95 vs KN95 face masks: What’s the difference?
Which one protects you best, and where can you buy them online?
9 tips for founders I learned from launching a startup in a pandemic
Here’s what Ryan Edwards-Pritchard learned so far about building a startup in the grips of a pandemic.
How to watch Arsenal vs Liverpool in the Carabao Cup live and free in Australia
Arsenal and Liverpool are locked at 0-0 ahead of their Carabao Cup semi-final second leg this week.
Australian rapid antigen test statistics
Heres how stock levels and prices are holding up for RATs in Australia.
How to Stake Olympus DAO (OHM)
Learn how to stake OHM and receive high yield from one of DeFi's most ambitious experiments.
Retroactive airdrop farming: How to prepare yourself for 2022
Being early to a new DeFi ecosystem can be very profitable – here's how to game the system and potentially earn yourself some tokens.
What is reporting season and why does it matter to investors?
Reporting season is a 2-week or so period where investors can see the results for a large number of publicly traded companies.
Bank First Green Personal Loan review
Bank First’s variable rate green personal loan can be used to make environmentally friendly purchases for your home.
Ask an Expert